open
access
articl
term
creat
ive
commo
ns
attri
butio
nnonco
mmercial
licens
permit
use
distribut
reproduct
medium
provid
origin
work
properli
cite
use
commerci
purpos
background
middl
east
respiratori
syndrom
coronaviru
merscov
fulli
understood
regard
certain
transmiss
rout
pathogenesi
lack
specif
therapeut
vaccin
pose
global
threat
public
health
simul
clinic
aerosol
transmiss
rout
transgen
mice
infect
merscov
anim
noseonli
exposur
devic
compar
instillationinocul
mice
challeng
mice
observ
consecut
day
necropsi
day
analyz
viral
load
histopatholog
viral
antigen
distribut
cytokin
tissu
show
weight
loss
day
obviou
lung
lesion
day
high
viral
load
lung
day
brain
day
surviv
merscov
instillationinocul
mice
exhibit
clinic
sign
day
obviou
lung
lesion
day
continu
weight
loss
surviv
day
high
viral
load
lung
brain
day
viral
antigen
high
level
proinflammatori
cytokin
chemokin
detect
aerosol
instil
group
diseas
lung
lesion
viral
replic
progress
slower
merscov
aerosolinfect
mice
merscov
instillationinocul
mice
conclus
transgen
mice
success
infect
merscov
aerosol
via
anim
noseonli
exposur
devic
aerosoland
instillationinfect
mice
simul
clinic
symptom
moder
diffus
interstiti
pneumonia
howev
transgen
mice
expos
aerosol
merscov
develop
diseas
lung
patholog
progress
close
resembl
observ
human
anim
noseonli
exposur
devic
transgen
mice
intranas
instil
merscov
aerosol
infect
middl
east
respiratori
syndrom
coronaviru
merscov
first
identifi
saudi
arabia
caus
acut
respiratori
ill
multiorgan
failur
shock
even
death
import
highli
pathogen
coronaviru
similar
sever
acut
respiratori
syndrom
coronaviru
sarscov
produc
sever
infect
high
mortal
rate
end
may
total
laboratoryconfirm
case
mer
associ
death
casefat
rate
higher
fatal
rate
sar
worldwid
accord
world
health
organ
statist
mer
case
report
countri
includ
countri
middl
east
africa
europ
asia
north
america
well
australia
case
number
continu
increas
pose
global
threat
public
health
china
first
patient
infect
merscov
south
korea
diagnos
may
extrem
import
prevent
control
treat
merscov
infect
futur
outbreak
henc
effect
small
anim
model
need
investig
viral
pathogenesi
evalu
merscov
therapeut
vaccin
nonhuman
primat
anim
model
merscov
rhesu
macaqu
common
marmoset
establish
previou
report
howev
model
limit
restrict
avail
high
cost
expert
husbandri
requir
ethic
concern
tradit
small
anim
mice
hamster
ferret
infect
merscov
owe
absenc
necessari
dipeptidyl
peptidas
receptor
interact
receptor
bind
domain
merscov
spike
protein
protein
merscov
fail
replic
mice
readili
avail
defin
genet
background
low
cost
frequent
use
infecti
diseas
research
due
variat
receptor
previou
studi
show
transgen
mice
express
human
receptor
could
infect
intranas
merscov
develop
acut
pneumonia
therefor
transgen
mice
select
exposur
merscovcontain
aerosol
use
anim
noseonli
exposur
devic
two
mode
merscov
infect
animaltohuman
humantohuman
transmiss
report
found
airborn
transmiss
via
cough
sneez
infect
dromedari
camel
contact
respiratori
secret
consumpt
unsteril
milk
infect
camel
significantli
increas
risk
merscov
infect
human
kim
et
al
discov
extens
viabl
merscov
contamin
air
surround
environ
mer
isol
ward
accord
suggest
humantohuman
transmiss
limit
extent
caus
inhal
droplet
airborn
viru
close
contact
patient
studi
demonstr
merscov
risk
aerosol
transmiss
addit
aerosol
inhal
main
clinic
rout
infect
viral
respiratori
ill
differ
clinic
present
anim
model
establish
differ
infect
rout
compar
studi
use
approach
differ
perspect
contribut
deeper
understand
mer
work
simul
aerosol
transmiss
rout
comparison
instil
rout
transgen
mice
expos
merscov
aerosol
anim
noseonli
exposur
devic
infect
analyz
mous
characterist
weight
loss
surviv
viral
replic
tissu
patholog
viral
antigen
distribut
cytokin
chemokin
profil
provid
addit
data
investig
pathogenesi
merscovinduc
diseas
evalu
relev
therapeut
vaccin
specif
pathogenfre
transgen
mice
express
anim
fed
condit
day
start
studi
two
consecut
day
prior
infect
mous
train
anim
noseonli
aerosol
devic
infect
mice
kept
laboratori
throughout
studi
observ
daili
ensur
enough
water
food
merscov
human
betacoronaviru
complet
genom
genbank
provid
ila
cam
viru
propag
expand
vero
cell
american
type
cultur
collect
usa
cultur
passag
co
routin
method
purifi
concentr
progeni
virus
titrat
use
vero
cellbas
infect
assay
viral
titer
express
unit
tissu
cultur
infecti
dose
per
microlit
tcid
merscov
stock
concentr
tcid
store
anim
noseonli
aerosol
exposur
devic
intox
product
locat
laboratori
compris
noseonli
exposur
chamber
nebul
insid
class
biolog
safeti
cabinet
bsc
control
box
mous
restraint
tube
clean
compress
air
tank
vacuum
pump
figur
exposur
devic
expos
mous
nose
gener
merscov
aerosol
particl
infect
transgen
mice
express
simul
natur
rout
infect
shown
tabl
transgen
mice
randomli
assign
aerosol
group
instil
group
aerosol
control
group
instil
control
group
bodi
weight
mous
measur
day
infect
day
group
contain
mice
five
mice
group
use
analyz
clinic
symptom
weight
loss
surviv
three
mice
group
randomli
chosen
necropsi
day
postinfect
merscov
viru
suspens
tcid
serumfre
dulbecco
modifi
eagl
medium
dmem
separ
ad
nebul
reservoir
infect
expos
mice
aerosol
control
aerosol
group
respect
minut
accord
instruct
exposur
devic
mous
respiratori
rate
mlmin
per
mous
nebul
flow
rate
set
l
min
dilut
flow
rate
set
lmin
nebul
pressur
set
psi
mice
anesthet
tribromoethanol
g
bodi
weight
intramuscular
im
intranas
inocul
tcid
merscov
instil
group
serumfre
dmem
instil
control
group
infect
mice
observ
consecut
day
analyz
clinic
symptom
diseas
weight
chang
surviv
mice
euthan
tribromoethanol
g
bodi
weight
im
reach
weight
loss
aerosol
control
dmem
aerosol
analyz
clinic
sign
weight
loss
surviv
instil
control
dmem
suspens
analyz
clinic
sign
weight
loss
surviv
day
postinfect
three
anim
randomli
select
group
underw
necropsi
obtain
tissu
specimen
assess
viral
distribut
associ
histopatholog
cytokin
level
use
quantit
revers
transcriptionpcr
qrtpcr
hematoxylin
eosin
h
e
stain
immunohistochemistri
ihc
enzymelink
immunosorb
assay
elisa
total
viral
rna
extract
tissu
lung
brain
kidney
spleen
liver
heart
intestin
homogen
use
rneasi
control
standard
curv
gener
pcr
use
copi
qualifi
standard
plasmid
calcul
copi
number
reaction
formalinfix
lung
brain
kidney
sampl
embed
paraffin
wax
section
approxim
thick
deparaffin
hydrat
tissu
section
routin
stain
h
e
examin
histopatholog
chang
immunohistochem
stain
perform
assess
express
viral
antigen
use
rabbit
twostep
detect
kit
zhongshan
golden
bridg
biotechnolog
co
ltd
rabbit
polyclon
antimerscov
nucleoprotein
np
antibodi
sino
biolog
inc
visual
perform
dab
stain
hematoxylin
counterstain
supernat
tissu
homogen
infect
mice
ad
bottom
antibodyco
plate
level
interleukin
il
tumor
necrosi
factor
tnf
interferon
ifn
assay
use
elisa
kit
kete
biotechnolog
co
ltd
chemokin
cytokin
concentr
record
pgml
homogen
ngl
homogen
data
analyz
use
spss
graphpad
prism
softwar
experiment
result
present
mean
plu
standard
deviat
sd
oneway
anova
use
assess
differ
bodi
weight
viral
load
cytokin
level
among
differ
group
student
test
perform
twogroup
comparison
p
consid
statist
signific
infect
mice
aerosol
instil
group
display
signific
clinic
symptom
huddl
hunch
ruffl
fur
weight
loss
death
signific
differ
weight
chang
p
surviv
p
merscov
infect
group
control
group
incub
period
howev
day
aerosol
infect
day
instil
inocul
merscov
aerosol
exposur
transgen
mice
show
profound
clinic
sign
day
rapid
weight
loss
day
surviv
day
acut
death
euthanasia
weight
loss
intranas
infect
transgen
mice
display
rapid
weight
loss
day
surviv
day
acut
death
euthanasia
weight
loss
signific
differ
diseas
progress
p
challeng
aerosol
group
instil
group
transgen
mice
infect
merscov
aerosol
exhibit
milder
diseas
slower
diseas
progress
inocul
intranas
figur
b
obviou
abnorm
includ
weight
loss
sign
clinic
ill
detect
aerosol
control
instil
control
group
signific
differ
weight
chang
surviv
rate
mice
inocul
dmem
two
control
group
p
figur
base
qrtpcr
analys
tissu
rna
content
identifi
high
viral
load
lung
brain
mice
small
amount
viral
rna
tissu
merscov
infect
via
aerosol
instil
rout
figur
b
howev
signific
differ
tissu
viral
load
infect
mice
two
group
p
merscov
aerosol
infect
high
viral
load
detect
lung
day
brain
day
viral
load
high
lung
brain
intranas
infect
mice
day
signific
differ
p
viral
load
lung
brain
two
group
day
viral
load
lung
brain
mice
aerosol
group
significantli
lower
mice
instil
group
high
level
viral
rna
accumul
slowli
tissu
merscov
aerosolexpos
mice
mice
infect
intranas
figur
shown
figur
data
present
mean
chang
sd
group
n
mice
instil
group
die
acut
euthan
reach
weight
loss
mice
surviv
rate
day
produc
result
weight
loss
day
key
indic
color
code
group
provid
figur
p
p
p
p
mice
instil
group
die
acut
euthan
research
weight
loss
mice
surviv
rate
day
tissu
lesion
result
avail
day
mice
infect
merscov
via
aerosol
inhal
intranas
instil
rout
obviou
lesion
found
tissu
abnorm
tissu
normal
control
group
clear
appear
lung
exhibit
obviou
congest
dark
brown
region
day
aerosol
group
merscovintranas
mice
show
gross
lung
lesion
day
sever
lung
lesion
day
gross
lung
lesion
develop
slowli
milder
aerosol
group
instil
group
figur
microscop
challeng
mice
develop
moder
acut
interstiti
pneumonia
brain
patholog
patholog
chang
detect
tissu
mice
aerosol
group
lung
expos
mice
show
alveolar
septal
widen
inflammatori
cell
infiltr
vessel
dilat
congest
day
gradual
develop
sever
patholog
chang
inflammatori
cell
infiltr
perivascular
region
day
focal
hemorrhag
day
expand
patholog
rang
day
figur
dilat
congest
cerebr
vessel
clearli
observ
day
area
neuron
deform
necrosi
found
cerebr
cortex
hippocampu
thalamu
day
figur
day
intranas
infect
found
moder
acut
interstiti
pneumonia
brain
lesion
figur
c
tissu
lesion
howev
milder
aerosol
group
instil
group
furthermor
signific
differ
progress
lung
brain
lesion
two
infect
group
tissu
lesion
progress
slower
aerosolinfect
mice
instillationinfect
mice
tabl
express
merscov
antigen
primarili
evalu
use
ihc
assay
found
endotheli
cell
alveolar
pneumocyt
lung
cerebr
cortic
neuron
dendrit
axon
microglia
hippocampu
brain
aerosoland
instillationchalleng
mice
control
mice
figur
b
promin
merscov
express
also
observ
renal
tubular
epitheli
cell
figur
howev
signific
differ
time
viru
express
tissu
mice
postinfect
merscov
infect
ihc
assay
rabbit
polyclon
antimerscov
np
antibodi
found
viral
antigen
predominantli
appear
tracheal
endotheli
cell
day
postinfect
lung
aerosolinfect
mice
tracheal
endotheli
cell
pneumocyt
lung
aerosolinfect
mice
day
chang
observ
lung
instillationinfect
mice
day
respect
addit
merscov
antigen
discov
brain
kidney
aerosol
group
day
instil
group
day
base
result
conclud
distribut
merscov
antigen
lung
brain
kidney
infect
slower
aerosol
group
instil
group
signific
differ
level
relat
proinflammatori
cytokin
chemokin
profil
includ
infecti
group
aerosol
group
instil
group
control
group
p
significantli
elev
level
discov
lung
brain
mice
aerosol
group
increas
day
p
postchalleng
mice
instil
group
day
postchalleng
figur
aerosol
group
expos
mice
show
peak
concentr
lung
concentr
brain
day
peak
level
lung
brain
peak
level
appar
chang
mild
alveolar
septum
widen
moder
alveolar
septum
widen
sever
alveolar
septum
widen
b
appar
chang
infiltr
interstiti
inflammatori
cell
interstiti
inflammatori
cell
infiltr
c
appar
chang
small
amount
exud
alveoli
appar
chang
mild
dilat
congest
vessel
moder
dilat
congest
vessel
e
appar
chang
mild
hemorrhag
f
nd
done
mice
instil
group
die
acut
euthan
reach
weight
loss
occur
day
f
g
u
r
e
immunohistochem
stain
mous
tissu
sampl
infect
immunohistochem
stain
lung
infect
mice
b
immunohistochem
stain
brain
infect
mice
c
immunohistochem
stain
kidney
infect
mice
mice
instil
group
die
acut
euthan
research
weight
loss
mice
surviv
rate
day
tissu
lesion
result
avail
day
day
intranas
infect
howev
level
lung
brain
peak
day
secret
cytokin
chemokin
aerosol
group
slower
intranas
group
p
mice
instil
group
die
acut
euthan
research
weight
loss
mice
surviv
rate
day
result
avail
day
result
repres
mean
sd
group
n
p
p
p
p
distribut
tissu
aerosoland
instillationchalleng
mice
tabl
merscov
infect
diseas
progress
mice
aerosol
group
slower
mice
instil
group
sander
et
al
show
viru
droplet
deposit
concentr
lung
respiratori
tract
mice
inocul
intranas
result
fast
diseas
onset
correspondingli
instil
infect
merscov
found
mice
short
airway
high
concentr
viru
deposit
lung
display
weight
loss
day
lung
lesion
day
consist
intranas
mous
model
establish
adam
agraw
li
et
al
mice
also
exhibit
surviv
day
previou
studi
report
aerosol
particl
penetr
respiratori
tract
reach
alveoli
diffus
distribut
lung
addit
viru
aerosol
enter
blood
circul
alveoli
virus
slowli
replic
lung
mice
inhal
merscovcontain
aerosol
particl
size
compar
instillationinocul
mice
viru
deposit
lung
aerosolexpos
mice
display
slower
diseas
progress
incub
period
day
lung
lesion
day
continu
weight
loss
day
milder
clinic
sign
surviv
day
found
progress
viru
replic
lung
lesion
challeng
mice
slower
aerosol
group
instil
group
base
high
viral
load
lung
brain
challeng
mice
consist
previou
report
acut
renal
failur
mer
patient
carri
h
e
stain
assess
histopatholog
chang
immunohistochem
stain
specif
antibodi
character
merscov
express
lung
brain
kidney
rel
high
viral
load
lower
respiratori
tract
associ
sever
ill
viral
respiratori
diseas
day
postinfect
mice
intranas
group
high
viral
load
lung
brain
day
exhibit
acut
interstiti
pneumonia
patholog
brain
chang
aerosol
group
mice
develop
acut
interstiti
pneumonia
day
patholog
brain
chang
day
caus
high
level
viru
rna
lung
day
brain
day
respect
higher
viru
rna
level
instil
group
might
contribut
sever
high
level
day
high
level
day
high
level
day
histopatholog
lung
moder
acut
interstiti
pneumonia
day
moder
acut
interstiti
pneumonia
day
brain
rel
mild
brain
lesion
day
brain
lesion
day
lung
bronchial
endotheli
cell
day
tracheal
endotheli
cell
alveolar
pneumocyt
lung
day
tracheal
endotheli
cell
alveolar
pneumocyt
lung
day
cerebr
cortic
neuron
dendrit
axon
glial
cell
hippocampu
day
cerebr
cortic
neuron
dendrit
axon
glial
cell
hippocampu
day
renal
tubular
epitheli
cell
day
renal
tubular
epitheli
cell
day
cytokin
chemokin
b
high
level
day
includ
high
level
day
middl
east
respiratori
syndrom
patient
exhibit
median
incub
period
day
rang
day
discov
instillationinocul
mice
exhibit
clinic
sign
within
day
incub
period
aerosolexpos
mice
day
close
resembl
period
observ
human
merscov
bind
receptor
primarili
express
lower
respiratori
tract
alveoli
result
wide
rang
diseas
symptom
patient
symptom
mild
respiratori
ill
sever
acut
pneumonia
rapidli
progress
acut
lung
damag
multiorgan
failur
even
death
clinic
chest
radiographi
chest
comput
tomographi
ct
show
lung
lesion
patient
earli
stage
ill
pneumonia
identifi
cours
diseas
includ
patchi
densiti
extens
diffus
focal
alveolar
space
opac
interstiti
infiltr
consolid
pulmonari
patholog
chang
aerosolinfect
mice
similar
note
patient
respiratori
tract
infect
addit
immunohistochem
stain
reveal
merscov
antigen
express
alveolar
pneumocyt
endotheli
cell
brain
kidney
challeng
transgen
mice
studi
fatal
case
merscov
infect
evidenc
express
merscov
antigen
predominantli
local
pneumocyt
endotheli
cell
result
cell
necrosi
pneumocyt
damag
howev
viral
antigen
detect
tissu
fatal
case
demonstr
previou
studi
also
discov
high
viral
load
patholog
chang
express
merscov
antigen
brain
challeng
mice
brain
lesion
multiorgan
damag
observ
mer
patient
zhou
et
al
demonstr
human
dendrit
cell
macrophag
permiss
merscov
replic
indic
multiorgan
injuri
induc
merscov
may
associ
distribut
receptor
mani
cell
type
spread
throughout
multipl
organ
studi
indic
merscov
cell
tissu
tropism
especi
tropism
pneumocyt
neuron
synaps
may
one
structur
virus
diffus
brain
merscov
infect
mechan
underli
brain
lesion
death
induc
merscov
infect
transgen
mice
remain
complex
complic
need
investig
transgen
mice
success
infect
merscov
aerosol
anim
noseonli
exposur
devic
aerosoland
instillationinfect
mice
simul
clinic
symptom
moder
diffus
interstiti
pneumonia
compar
instillationinfect
mice
aerosolinfect
mice
close
resembl
infect
human
term
progress
diseas
patholog
lung
provid
addit
data
studi
pathogenesi
evalu
efficaci
prevent
therapeut
agent
merscov
current
work
support
nation
scienc
technolog
major
project
infecti
diseas
grant
number
none
hg
princip
investig
design
supervis
studi
wrote
grant
applic
xyh
perform
main
experi
xyh
ql
perform
cell
experi
xyh
fdl
conduct
anim
experi
yfx
complet
patholog
experi
xyh
hg
conceiv
experi
analyz
data
wrote
paper
author
read
approv
final
manuscript
xinyan
hao
http
